Literature DB >> 17311292

Defining the involvement of proteinases in pemphigus vulgaris: evidence of matrix metalloproteinase-9 overexpression in experimental models of disease.

Nicola Cirillo1, Michele Lanza, Luigi Rossiello, Fernando Gombos, Alessandro Lanza.   

Abstract

Pemphigus vulgaris (PV) acantholysis represents a complex phenomenon wherein a number of factors cooperates. PV serum is known to modulate important cellular events, including kinase activity, transcriptional regulation, and proteinase expression. Indeed, transduction of signals to the cell triggered by PV serum may induce proteinase up-regulation potentially responsible for disruption of epidermal adhesion and, ultimately, blister formation. Here, we sought to investigate this hypothesis by using both in vivo and in vitro models of PV. Microarray analysis on mouse skin tissues suggested that the equilibrium between extracellular proteinases and their inhibitors moved towards enhanced proteolytic activity in PV neonatal mouse model, at least on the transcriptional level. Conversely, genes codifying cell adhesion proteins were dramatically down-regulated. The effects of PV serum on the protein level were then studied in vitro both in keratinocyte monolayers and skin organ cultures focusing on matrix metalloproteinase (MMP) 9 expression and activity. By means of Western blotting, zymography, and living cell immunofluorescence studies, we showed that MMP-9 was early overexpressed in keratinocytes exposed to PV serum, and subsequently secreted in the culture medium. However, we failed to demonstrate extracellular activation of MMP-9, since it was found in its 92 kDa inactive form in serum-free culture supernatants. Taken together, our data demonstrated that proteinase expression, particularly of MMP-9, is modulated by PV serum and associated with PV acantholysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311292     DOI: 10.1002/jcp.20997

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  A novel method to investigate pemphigus-induced keratinocyte dysmorphisms through living cell immunofluorescence microscopy.

Authors:  Nicola Cirillo; Felice Femiano; Antonio Dell'Ermo; Pietro Arnese; Fernando Gombos; Alessandro Lanza
Journal:  Virchows Arch       Date:  2007-04-21       Impact factor: 4.064

2.  Respiratory function in patients with pemphigus vulgaris - a small clinical study.

Authors:  Zoi Apalla; Diamantis Chloros; Paraskevi Argyropoulou; Dimitrios Georgopoulos; Dimitrios Patakas; Dimitrios Spanos; George Chaidemenos
Journal:  J Dermatol Case Rep       Date:  2011-03-26

Review 3.  The desmosome and pemphigus.

Authors:  Jens Waschke
Journal:  Histochem Cell Biol       Date:  2008-04-03       Impact factor: 4.304

4.  Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion.

Authors:  Y Hassona; N Cirillo; K Heesom; E K Parkinson; S S Prime
Journal:  Br J Cancer       Date:  2014-08-12       Impact factor: 7.640

Review 5.  The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the "Super Compensation Hypothesis".

Authors:  Animesh A Sinha; Thomas Sajda
Journal:  Front Med (Lausanne)       Date:  2018-08-14

Review 6.  A Scoping Review of the Role of Metalloproteinases in the Pathogenesis of Autoimmune Pemphigus and Pemphigoid.

Authors:  Nicola Cirillo; Stephen S Prime
Journal:  Biomolecules       Date:  2021-10-13

Review 7.  Caspase Inhibition as a Possible Therapeutic Strategy for Pemphigus Vulgaris: A Systematic Review of Current Evidence.

Authors:  Sanna Huda; Bethany Chau; Chuanqi Chen; Herman Somal; Neiloy Chowdhury; Nicola Cirillo
Journal:  Biology (Basel)       Date:  2022-02-16

Review 8.  A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy.

Authors:  Payal M Patel; Virginia A Jones; Christy T Behnam; Giovanni Di Zenzo; Kyle T Amber
Journal:  Antibodies (Basel)       Date:  2021-05-17

9.  MMP-9 and CXCL8/IL-8 are potential therapeutic targets in epidermolysis bullosa simplex.

Authors:  Thomas Lettner; Roland Lang; Alfred Klausegger; Stefan Hainzl; Johann W Bauer; Verena Wally
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.